|Articles|January 29, 2016
Hep C, Melanoma Drug Approvals Highlight Week in Specialty Pharmacy
Author(s)Davy James, Managing Editor
Top stories of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/hep-c-melanoma-drug-approvals-highlight-week-in-sp" target="_blank">View the story "Hep C, Melanoma Drug Approvals Highlight Week in Specialty Pharmacy" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Reformulated Ranitidine After 5-Year Absence
2
Gluteus Maximus Muscle Shape Changes Tied to Aging, Frailty, and Type 2 Diabetes
3
Redefining the Role of GLP-1 Therapies: The Clinical Trials Behind the Expanding Indications
4
Understanding Cyclobenzaprine Hydrochloride: An Emerging Therapy for Fibromyalgia
5
